share_log

中國中藥：聯合公告有關(1)要約人根據公司條例第673條通過計劃安排的方式將中國中藥控股有限公司私有化之附先決條件之建議及(2)建議撤銷中國中藥控股有限公司的上市地位之每月更新情況

TRAD CHI MED: JOINT ANNOUNCEMENTMONTHLY UPDATEIN RELATION TO(1) PRE-CONDITIONAL PROPOSAL TO PRIVATISECHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITEDBY THE OFFERORBY WAY OF A SCHEME OF ARRANGEMENTUNDER SECTION 673 OF THE COMPANIES ORDINANCEAND(2) PROPOSED WITHDRA

Hong Kong Stock Exchange ·  Jul 15 04:39
Summary by Moomoo AI
國藥集團共裕有限公司（「要約人」）正透過計劃安排的方式，提出私有化中國中藥控股有限公司的建議，並建議撤銷其上市地位。自2024年2月21日起，要約人及中國中藥控股有限公司已發布多份聯合公告，更新私有化進程及每月情況。最新公告顯示，要約人正在完成與適用的境外直接投資法律法規及中國反壟斷法相關的必要通知、備案或申請，以滿足私有化的先決條件。股東及潛在投資者被提醒，建議的實施仍需等待先決條件的滿足或豁免。中國中藥控股有限公司將會在適當時候發布進一步公告。本公告由董事會主席陳映龍先生代表董事會發布，日期為2024年7月15日。
國藥集團共裕有限公司（「要約人」）正透過計劃安排的方式，提出私有化中國中藥控股有限公司的建議，並建議撤銷其上市地位。自2024年2月21日起，要約人及中國中藥控股有限公司已發布多份聯合公告，更新私有化進程及每月情況。最新公告顯示，要約人正在完成與適用的境外直接投資法律法規及中國反壟斷法相關的必要通知、備案或申請，以滿足私有化的先決條件。股東及潛在投資者被提醒，建議的實施仍需等待先決條件的滿足或豁免。中國中藥控股有限公司將會在適當時候發布進一步公告。本公告由董事會主席陳映龍先生代表董事會發布，日期為2024年7月15日。
Guoyao Group Gongyu Co., Ltd. (the "Offeror") is proposing privatization of China Traditional Chinese Medicine Holdings Co., Ltd. ("China Traditional Chinese Medicine") and suggesting the revocation of its listing status through a planned arrangement. Since February 21, 2024, the Offeror and China Traditional Chinese Medicine have jointly issued multiple announcements updating the privatization process and monthly progress. The latest announcement shows that the Offeror is completing the necessary notices, filings or applications related to applicable overseas direct investment laws and regulations and China's antitrust laws to meet the precondition of privatization. Shareholders and potential investors are reminded that the implementation of the proposal is still subject to the satisfaction or waiver of precondition. China Traditional Chinese Medicine will release further announcements at the appropriate time. This announcement is issued on behalf of the Board of Directors by Mr. Chen Yinglong, Chairman of the Board of Directors, dated July 15, 2024.
Guoyao Group Gongyu Co., Ltd. (the "Offeror") is proposing privatization of China Traditional Chinese Medicine Holdings Co., Ltd. ("China Traditional Chinese Medicine") and suggesting the revocation of its listing status through a planned arrangement. Since February 21, 2024, the Offeror and China Traditional Chinese Medicine have jointly issued multiple announcements updating the privatization process and monthly progress. The latest announcement shows that the Offeror is completing the necessary notices, filings or applications related to applicable overseas direct investment laws and regulations and China's antitrust laws to meet the precondition of privatization. Shareholders and potential investors are reminded that the implementation of the proposal is still subject to the satisfaction or waiver of precondition. China Traditional Chinese Medicine will release further announcements at the appropriate time. This announcement is issued on behalf of the Board of Directors by Mr. Chen Yinglong, Chairman of the Board of Directors, dated July 15, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more